MiNK Therapeutics INKT
NASDAQ INKT
$12.44 -0.29 (-2.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Depreciation & Amortization (CF) (2020 - 2026)

Updated

MiNK Therapeutics' Depreciation & Amortization (CF) came in at $36,064 for Q2 2026, down 26.0% from $48,763 a year earlier and unchanged from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, MiNK Therapeutics reported Depreciation & Amortization (CF) of $154,347, down 28.6% year-over-year; for FY2025, it was $181,745, down 15.6% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 27.0% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $215,437 in FY2024 (+5.3%), $204,617 in FY2023 (+68.1%), $121,749 in FY2022 (+56.2%) and $77,960 in FY2021 (+41.6%).
  • The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q3 2022.
  • Year-over-year, Depreciation & Amortization (CF) has declined for four consecutive quarters, with an average decline of 11.7% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2023 (growth of 88.0%), and the weakest in Q3 2025 (a decline of 30.3%).
  • Business Quant data shows INKT's Depreciation & Amortization (CF) at $36,066 (Q1 2026), $38,563 (Q4 2025) and $43,654 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 MiNK Therapeutics 64.88 Mn 64.88 Mn - 36,064.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36,064.00
Mar 31, 2026 36,066.00
Dec 31, 2025 38,563.00
Sep 30, 2025 43,654.00
Jun 30, 2025 48,763.00
Mar 31, 2025 50,765.00
Dec 31, 2024 53,869.00
Sep 30, 2024 62,637.00
Jun 30, 2024 45,100.00
Mar 31, 2024 53,831.00
Dec 31, 2023 53,572.00
Sep 30, 2023 53,453.00
Jun 30, 2023 51,906.00
Mar 31, 2023 45,686.00
Dec 31, 2022 37,933.00
Sep 30, 2022 28,430.00
Jun 30, 2022 28,309.00
Mar 31, 2022 27,077.00
Dec 31, 2021 23,834.00
Sep 30, 2021 20,285.00
API Access

MiNK Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INKT&period=max&api_key=YOUR_API_KEY